NM_000096.4:c.1652C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000096.4(CP):​c.1652C>T​(p.Thr551Ile) variant causes a missense change. The variant allele was found at a frequency of 0.031 in 1,612,482 control chromosomes in the GnomAD database, including 978 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 65 hom., cov: 32)
Exomes 𝑓: 0.032 ( 913 hom. )

Consequence

CP
NM_000096.4 missense

Scores

5
8
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:13

Conservation

PhyloP100: 6.57

Publications

15 publications found
Variant links:
Genes affected
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
CP Gene-Disease associations (from GenCC):
  • aceruloplasminemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • disorder of iron metabolism and transport
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01101324).
BP6
Variant 3-149198428-G-A is Benign according to our data. Variant chr3-149198428-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 42125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0549 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPNM_000096.4 linkc.1652C>T p.Thr551Ile missense_variant Exon 9 of 19 ENST00000264613.11 NP_000087.2 P00450A5PL27

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPENST00000264613.11 linkc.1652C>T p.Thr551Ile missense_variant Exon 9 of 19 1 NM_000096.4 ENSP00000264613.6 P00450

Frequencies

GnomAD3 genomes
AF:
0.0227
AC:
3460
AN:
152130
Hom.:
66
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00655
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0191
Gnomad ASJ
AF:
0.0294
Gnomad EAS
AF:
0.00192
Gnomad SAS
AF:
0.0610
Gnomad FIN
AF:
0.0188
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0326
Gnomad OTH
AF:
0.0268
GnomAD2 exomes
AF:
0.0285
AC:
7148
AN:
251032
AF XY:
0.0311
show subpopulations
Gnomad AFR exome
AF:
0.00591
Gnomad AMR exome
AF:
0.0167
Gnomad ASJ exome
AF:
0.0326
Gnomad EAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.0227
Gnomad NFE exome
AF:
0.0307
Gnomad OTH exome
AF:
0.0304
GnomAD4 exome
AF:
0.0319
AC:
46572
AN:
1460234
Hom.:
913
Cov.:
30
AF XY:
0.0330
AC XY:
23995
AN XY:
726518
show subpopulations
African (AFR)
AF:
0.00568
AC:
190
AN:
33472
American (AMR)
AF:
0.0170
AC:
762
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0300
AC:
783
AN:
26128
East Asian (EAS)
AF:
0.00222
AC:
88
AN:
39694
South Asian (SAS)
AF:
0.0646
AC:
5569
AN:
86180
European-Finnish (FIN)
AF:
0.0235
AC:
1254
AN:
53412
Middle Eastern (MID)
AF:
0.0472
AC:
272
AN:
5764
European-Non Finnish (NFE)
AF:
0.0322
AC:
35770
AN:
1110522
Other (OTH)
AF:
0.0312
AC:
1884
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
2079
4158
6236
8315
10394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1354
2708
4062
5416
6770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0227
AC:
3456
AN:
152248
Hom.:
65
Cov.:
32
AF XY:
0.0227
AC XY:
1691
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00655
AC:
272
AN:
41522
American (AMR)
AF:
0.0191
AC:
292
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
102
AN:
3472
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5184
South Asian (SAS)
AF:
0.0606
AC:
292
AN:
4818
European-Finnish (FIN)
AF:
0.0188
AC:
200
AN:
10612
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0326
AC:
2220
AN:
68018
Other (OTH)
AF:
0.0256
AC:
54
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
173
345
518
690
863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0271
Hom.:
15
Bravo
AF:
0.0204
TwinsUK
AF:
0.0286
AC:
106
ALSPAC
AF:
0.0324
AC:
125
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.0301
AC:
259
ExAC
AF:
0.0288
AC:
3498
Asia WGS
AF:
0.0270
AC:
94
AN:
3478
EpiCase
AF:
0.0316
EpiControl
AF:
0.0305

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of ferroxidase Pathogenic:1Benign:6
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 12, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 18, 2013
GeneReviews
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:curation

- -

Feb 01, 2017
GenePathDx, GenePath diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

25 years old, suspected case of Aceruloplasminemia. Next generation DNA sequencing ofperipheral blood sample has revealed the presence of two homozygous variants in the CP gene. The c.1652C>T variant is being classified as a ‘Variant of Unknown Significance, likely benign’, while the c.1679G>T variant is being classified as a ‘Variant of Unknown Significance, likely pathogenic’ based on available evidence in the databases and in silico mutation prediction methods. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:4
Jun 16, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.75
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.060
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
.;T
Eigen
Pathogenic
0.69
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.93
.;D
MetaRNN
Benign
0.011
T;T
MetaSVM
Uncertain
0.57
D
PhyloP100
6.6
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-2.9
D;D
REVEL
Pathogenic
0.67
Sift
Uncertain
0.0010
D;D
Sift4G
Pathogenic
0.0010
D;D
Vest4
0.090
MPC
0.47
ClinPred
0.027
T
GERP RS
5.5
gMVP
0.90
Mutation Taster
=42/58
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61733458; hg19: chr3-148916215; API